The anthracycline quinone doxorubicin (DOX; adriamycin) is prescribed for the treatment of several human tumors and leukemias. Despite its recognized effectiveness against such neoplasias, the clinical success of DOX is limited due to its dose dependent and cumula tive cardiotoxicity [1] . DOX generates oxygen free radicals as a consequence of undergoing redox cycling on complex I of the mitochondrial electron transport chain [2, 3] , with the resulting oxidative stress being implicated as a primary cause of doxorubicin induced cardiac toxicity [4] . Mitochondrial oxidative damage and calcium overload, both of which are associated with DOX toxicity [5 8], are potent inducers of the mitochondrial permeability transi tion (MPT) [9] . Consequently, the pro oxidant nature of DOX has been implicated as a primary cause for its toxic ity. In fact, several authors have demonstrated that DOX and its metabolites decrease the mitochondrial calcium loading capacity that determines MPT pore opening, both in vitro [10, 11] and in vivo [5 8]. The evidence clearly sug gests that, by inducing the MPT, DOX interferes with mitochondrial calcium regulation, which may be one of the principal features in the pathogenesis of DOX induced cardiomyopathy. Furthermore, enhanced induction of the MPT in heart mitochondria may also be responsible for the decreased respiratory rates observed in heart mito chondria isolated from DOX treated animals [12] .
MPT induction [13] . The protein containing critical thiol residues has not been definitively identified, but was sug gested to be the adenine nucleotide translocator (ANT) [14] . The correlation between mitochondrial glutathione and thiol redox status, induction of the MPT, and inhibi tion of mitochondrial respiration suggests possible causal relationships amongst these otherwise independent events. However, it has yet to be demonstrated that oxida tion of thiol groups caused by DOX induced oxidative stress [15] is causally related to rendering mitochondria more susceptible to induction of the permeability transi tion. Also, it remains to be determined if the inhibition of mitochondrial respiration is a direct effect of DOX induced thiol oxidation or if it is secondary to induction of the MPT.
The present investigation was thus designed to assess whether increased MPT induction caused by in vivo DOX treatment is responsible for a secondary inhibition of state 3 respiration. We also investigated whether changed thiol status impacts in regulating both altered MPT and respi ration. The hypothesis was that cyclosporin A could revert the inhibition of respiration observed in DOX treated animals. Also, heart mitochondria from DOX treated samples were suspected to be more susceptible to the MPT induced by diamide, and that dithiothreitol (DTT), as a thiol reducing agent, is able to restore normal mito chondrial respiration.
MATERIALS AND METHODS
Chemicals. Ultra pure sucrose was obtained from Schwarz/Mann Biotech (USA). DOX was purchased from Pharmacia & Upjohn Co. (USA). Cyclosporin A was a gift from Sandoz Pharmaceuticals (USA). All other chemicals were of the highest grade available from Sigma Chemical Co. (USA).
Animals and treatment protocol. Male SpragueDawley rats (Harlan Labs, USA) weighing 200 300 g were maintained in AAALAC (Association for Assessment and Accreditation of Animal Laboratory Care) accredited, climate controlled facilities and allowed free access to food (Purina Chow) and water. All studies were carried out in accordance with the Guide for the Care and Use of Laboratory Animals. Rats were randomly divided in two experimental groups: saline (SAL) treated and DOX treated. Rats received seven weekly subcutaneous (s.c.) injections of either DOX (2 mg/kg) or an equivalent vol ume of SAL solution (1 ml/kg). DOX dosage was estab lished on the basis of previous studies that showed cardiac mitochondrial damage and histopathology [6, 7] . The animals were killed by decapitation one week after the last injection and the hearts immediately excised to cold buffer for mitochondrial isolation. Body and heart weights were recorded on the day of the experiments. At that time, DOX treated rats had a lower heart (1.17 ± 0.09 versus 1.54 ± 0.06 g, p < 0.05, n = 10) and body (287.3 ± 5.6 versus 386.6 ± 6.6 g, p < 0.05, n = 10) weight.
Isolation of cardiac mitochondria. Cardiac mito chondria were prepared by differential centrifugation. Briefly, the hearts were finely minced in an ice cold isola tion medium containing 250 mM sucrose, 1 mM EGTA, 10 mM HEPES KOH (pH 7.4), and 0.1% defatted bovine serum albumin (BSA). The minced tissue was sus pended in 40 ml of the isolation medium containing 0.5 mg protease type VIII (Sigma, P5390) per g of tissue and homogenized with a tightly fitted homogenizer (Teflon/glass). The suspension was incubated for 1 min (4°C) and then re homogenized. The homogenate was then centrifuged at 9500g for 10 min. The supernatant was decanted and the pellet was gently re suspended to its original volume. The suspension was centrifuged at 900g for 10 min, and the resulting supernatant was centrifuged at 9000g for 10 min. This pellet was resuspended using a brush and repelleted twice at 9000g for 10 min. EGTA and defatted BSA were omitted from the final washing medium. Mitochondrial protein content was determined by the Bradford method calibrated with BSA [16] . The yield of mitochondrial protein (mg protein/g heart tissue) was not different between treatment groups (5.5 ± 0.5 for SAL and 5.2 ± 0.2 for DOX group, n = 8).
Oxygen consumption. Oxygen consumption by iso lated heart mitochondria was monitored polarographical ly with a Clark oxygen electrode connected to a suitable recorder. Reactions were carried out at 25°C in 1 ml of media containing 100 mM KCl, 50 mM sucrose, 10 mM Tris Mops, 10 µM EGTA, and 2.5 mM KH 2 PO 4 (pH 7.4). Mitochondria were suspended at a concentra tion of 0.25 mg/ml in the respiratory medium. State 4 res piration was measured in the presence of 5 mM gluta mate/malate and ADP (210 nmol) was added to induce state 3 respiration. The ADP/O was calculated according to standard procedures [17] . Where indicated, Trolox (100 µM), DTT (1 mM), and cyclosporin A (0.5 µM) were added 3 min before mitochondrial energization.
Mitochondrial swelling. Mitochondrial volume changes were estimated by monitoring changes in light scattering measured at 540 nm. The assays were performed in 1.5 ml of non ionic media composed of 200 mM sucrose, 10 mM Tris Mops, 10 µM EGTA, 5 mM KH 2 PO 4 (pH 7.4, 25°C), and 2 µM rotenone to which was added 0.5 mg of mitochondrial protein. The incubation medium is different from the one used for respiratory experiments in order to provide better osmotic stability for mitochondria. Succinate (4 mM) was added 2 min after calcium addition (200 nmol CaCl 2 /mg protein). Diamide concentrations ranging from 0.665 to 13.33 µM were added 2 min after calcium addition. Initial rates of mito chondrial swelling were measured for at least 3 min after the onset of the decrease in absorbance. The time elapsed between diamide addition and the beginning of the initial decrease in the suspension absorbance was also recorded. Extraction and quantification of CoQ 9 , CoQ 10 , and vitamin E. Aliquots of mitochondria containing 1 mg of protein/ml were extracted according to the method described by Takada et al. [18] . The extract was evaporat ed to dryness under a stream of N 2 and resuspended in absolute ethanol. CoQ content was determined by reverse phase HPLC (Spherisorb RP18, S5ODS2 col umn). Samples were eluted with methanol-heptane (10 : 2 v/v) at a flow rate of 2 ml/min. Detection was per formed by an ultraviolet (UV) detector at 269 nm. Vitamin E was extracted and quantified by following the method described by Takayanagi et al. [19] . The extract was evaporated to dryness under a stream of N 2 and resus pended in n hexane. Vitamin E content was determined by reverse phase HPLC (4.6 × 200 mm; Spherisorb S10w column). Samples were eluted with n hexane supple mented with 0.9% methanol at a flow rate of 1.5 ml/min. Detection was performed by a UV detector at 287 nm.
Thiobarbituric acid reactive substances (TBARS) determination. TBARS content in mitochondrial samples was measured by HPLC according to Wong et al. [20] . Liquid chromatography was performed using Gilson (USA) HPLC apparatus with a reverse phase column (RP18, S5 ODS 2 ). The samples were eluted from the col umn at a flow rate of 1 ml/min and detection was per formed at 532 nm. The TBARS content in the samples was calculated from the standard curve prepared using the thiobarbituric-malonyldialdehyde complex and expressed in nmol/mg protein.
Statistical analysis. The results are presented as mean ± SEM of at least five independent experiments. Statistical comparison between selected experimental groups was performed by using Student's paired t test or paired ANOVA, followed by Bonferroni's post test. A p < 0.05 was considered statistically significant.
RESULTS
In our model for in vivo DOX induced mitochon drionopathy, oxidative stress to mitochondrial samples was confirmed on the basis of drug related changes in thiobarbituric acid reactive substances (TBARS) and vitamin E and coenzyme Q content as quantified by high performance liquid chromatography. Despite no changes in the mitochondrial content of coenzymes Q 9 and Q 10 , DOX treatment resulted in a 35% increase in cardiac TBARS and a 25% decrease in vitamin E content (table) .
Diamide, which is known to promote thiol cross linking [21] , was used to titrate the rate of mitochondrial swelling in the presence of calcium in order to assess treatment related alterations in the thiol dependent reg ulation of the MPT complex, as described previously [13, 21] . The rational behind this protocol is that oxidation of thiol groups in critical elements of the MPT pore com plex would be manifested as a susceptibility to diamide. Mitochondrial swelling in both saline and DOX treated animals demonstrated biphasic kinetics (Fig. 1a) . Swelling curves in the presence of 13 µM diamide showed that mitochondria from DOX treated animals displayed a shorter lag phase when compared with the corresponding control (9.8 ± 0.5 versus 12.6 ± 0.9 min, p < 0.05, n = 4). Furthermore, the rate of swelling with increasing concen trations of diamide was significantly greater in cardiac mitochondria isolated from DOX treated animals com pared to cardiac mitochondria isolated from saline treat ed control rats (Fig. 1b) . In particular, for the highest diamide concentration (13 µM), swelling rates were 0.0197 ± 0.0018 optical density unit per min for the DOX group compared to 0.0123 ± 0.0023 optical density unit per min for samples from saline treated rats (p < 0.05, n = 4) (Fig. 1b) .
Treatment of rats in vivo with DOX resulted in a sta tistically significant inhibition of state 3 respiration for cardiac mitochondria (Fig. 2b) , whereas there was no treatment related effect on state 4 respiration (Fig. 2a) . Although not shown, there was no treatment related dif ference in the phosphorylation efficiency of cardiac mitochondria isolated from DOX compared to saline treated rats (ADP/O ratio was 2.7 ± 0.1 versus 2.8 ± 0.2, respectively, n = 7), which is in accordance with previ ously published results [12] . Glutamate/malate was the substrate used in the experimental protocol as previous works showed a stronger inhibition of respiration by DOX when using this substrate [12] . The DOX induced inhibi tion of cardiac mitochondrial state 3 respiration was par tially reversed by both DTT and cyclosporin A. DTT by itself, however, exhibited a direct inhibition of state 3 res piration in cardiac mitochondria from saline treated rats. 
DISCUSSION
The widely described effect of DOX to generate oxy gen free radicals and cause generalized oxidative stress was evidenced by the loss of vitamin E and accumulation of products of lipid peroxidation (TBARS) in cardiac tis sue from drug treated rats. The results are consistent with previous reports that DOX causes oxidative stress in heart mitochondria [15, 22] , although no changes in the levels of coenzyme Q 9 and Q 10 were observed. The hypothesis of the present investigation was that the increased cardiac MPT observed in DOX treated rats is at least in part responsible for the inhibition of respiratory function in cardiac mitochondria. Also, our secondary hypothesis was that DOX induced oxidation of thiol residues in mitochondrial proteins [15, 22] is responsible not only for altering the MPT sensitivity to calcium and thiol target ed agents, but also for the effects of in vivo DOX treat ment on mitochondrial respiration. Diamide and DTT, two thiol specific agents, were used ex vivo to demonstrate that thiol redox status is changed in cardiac mitochondria from DOX treated rats, which may be partially responsi ble for the altered mitochondrial bioenergetics and open ing of the MPT pore. In fact, the results indicate that heart mitochondria isolated from DOX treated rats were more susceptible to ex vivo diamide induced swelling. Diamide, a bifunction al thiol cross linking agent [21] , increases the probability for pore opening due to oxidation of protein thiol sites that are in equilibrium with the mitochondrial pool of pyridine nucleotides and reduced glutathione [13] . Although the specific regulatory protein has not been conclusively identified, it has been suggested that the ade nine nucleotide translocator (ANT) is a major target for thiol dependent induction of the MPT and is most likely the protein containing the redox sensor of the pore [23, 24] . However, there remains some controversy regarding ANT as a primary component of the pore complex [25] . The shorter lag phase preceding diamide induced swelling in heart mitochondria from DOX treated ani mals suggests a greater degree of oxidized proteins involved in inducing the MPT pore. Initial swelling rates were also higher for heart mitochondria from DOX treat ed animals. The results suggest increased amounts of oxi dized thiol residues in proteins of the MPT pore complex in heart mitochondria from DOX treated rats, which may be a relevant factor for the enhanced calcium induced MPT detected in those animals. As mentioned above, the ANT is a primary target for thiol dependent regulation of the MPT pore. In fact, it has previously been demonstrat ed that decreased functional ANT protein numbers exist in hearts from DOX treated animals [7] . The decrease in mitochondrial antioxidants (such as vitamin E) may also be relevant because it could contribute to the lack of pro tection of critical protein thiol groups in the pore com plex against oxygen free radicals derived from DOX redox cycling.
State 4 respiration in DOX treated animals was not significantly different from saline control, which is con sistent with previously published results [6] . The higher ionic strength of the buffer used in these experiments may explain slight differences with previous reports [12] . Mitochondrial state 3 respiration was significantly depressed in DOX treated animals, which again confirms earlier reports [12] . The novelty in this study was that DTT and cyclosporin A, when added ex vivo, were inde pendently able to partially reverse the inhibitory effect of in vivo DOX treatment on state 3 respiration, indicating that the inhibition of mitochondrial respiration by DOX is in part secondary to oxidation of thiol groups and induction of the MPT, rather than exclusively being a direct effect of the drug itself. In contrast to DTT, Trolox did not restore mitochondrial respiration, which can be explained by a different mechanism of action (unrelated to specific targeting of thiol groups).
An alternate interpretation of our data is that the oxi dation of thiol groups occurs secondarily, rather than causally, to MPT induction, which would explain the effect of DTT on mitochondrial respiration of DOX treat ed animals. Evidence supporting this proposal is the result obtained by Zhou et al. [7] . The authors demonstrated that unlike cyclosporin A, DTT is not able to reverse the decrease in mitochondrial calcium loading capacity in cardiac mitochondria isolated from DOX treated rats. Nevertheless, the lack of inhibition of the MPT by DTT could also indicate a more permanent alteration of protein thiol residues in vivo that cannot be reversed by adding thiol reducing agents ex vivo. The data obtained with diamide titration suggests that oxidation of thiol residues occurs in vivo during DOX treatment and is relevant for the decreased calcium loading capacity [7, 12] .
The fact that both DTT and cyclosporin A, the spe cific MPT inhibitor [26] , were able to partially restore respiration in cardiac mitochondria isolated from DOX treated animals suggests that (i) the inhibition of mito chondrial respiration is secondary to MPT induction and (ii) DOX reversibly affects one or more proteins associat ed with oxidative phosphorylation that is also modulated by its thiol oxidation state. This later proposal is support ed by the fact that DTT inhibits state 3 respiration in heart mitochondria from saline treated rats (Fig. 2b) , as opposed to the partial improvement of respiration observed in the DOX treated group. One protein involved in mitochondrial energy metabolism and whose thiol sta tus determines its activity is mitochondrial complex I [27] , the activity of which has been shown to be decreased in DOX treated rats [12] . The mechanism relating decreased mitochondrial respiration and MPT alterations in DOX treated rats is so far unknown. There are never theless two likely possibilities. The first is that cyclosporin A may restore the activity of mitochondria that were pre viously non functional due to pore opening. Another hypothesis is that the binding of cyclosporin A to cyclophilin D [28] may cause the disaggregation of pre formed pores, thus allowing a crucial component to again become involved in the oxidative phosphorylation process.
In conclusion, the results of the current investigation provide the first evidence that in vivo oxidation of critical thiol residues in mitochondrial proteins following in vivo DOX treatment affects both the MPT pore and oxidative phosphorylation machinery. MPT induction would then be in part responsible for the observed decrease in mito chondrial respiration. A particular consequence of DOX toxicity is that mitochondrial proteins involved in both oxidative phosphorylation and in the MPT pore complex may be significantly more susceptible to external stimuli that would lead to an increase of intracellular oxidative stress. The results also establish a cause-effect relation between enhanced MPT activation and decreased mito chondrial respiration, which is indicated by the partial restoration of mitochondrial respiration by cyclosporin A, a potent and specific inhibitor of the MPT. Accordingly, the MPT may play a so far unknown role in modulating the adverse bioenergetic and functional consequences associated with DOX treatment.
